These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16458121)

  • 1. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
    Fuessel S; Herrmann J; Ning S; Kotzsch M; Kraemer K; Schmidt U; Hakenberg OW; Wirth MP; Meye A
    Cancer Lett; 2006 Feb; 232(2):243-54. PubMed ID: 16458121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
    Ning S; Fuessel S; Kotzsch M; Kraemer K; Kappler M; Schmidt U; Taubert H; Wirth MP; Meye A
    Int J Oncol; 2004 Oct; 25(4):1065-71. PubMed ID: 15375557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
    Hou JQ; He J; Wang XL; Wen DG; Chen ZX
    Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
    Kunze D; Wuttig D; Kausch I; Blietz C; Blumhoff L; Burmeister Y; Kraemer K; Fuessel S; Toma M; Schwenzer B; Meye A; Grimm MO; Hakenberg OW; Jocham D; Wirth MP
    Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells: Direct suppression of survivin and enhancement of transfection efficiency by topotecan.
    Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
    Int J Oncol; 2008 Jan; 32(1):171-6. PubMed ID: 18097556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
    Yuan-Jing F; Nan-Shan H; Lian X
    Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K; Hamasaki K; Ichikawa T; Arima K; Eguchi K; Ishii N
    Oncol Rep; 2006 Aug; 16(2):389-92. PubMed ID: 16820920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of survivin gene by vector-based short hairpin RNA technique induces apoptosis and growth inhibition in Burkitt's lymphoma Raji cell line.
    Gu CM; Zhu YK; Ma YH; Zhang M; Liao B; Wu HY; Lin HL
    Neoplasma; 2006; 53(3):206-12. PubMed ID: 16652189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells.
    Chao JI; Liu HF
    Mol Pharmacol; 2006 Jan; 69(1):154-64. PubMed ID: 16219911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.
    Kappler M; Bache M; Bartel F; Kotzsch M; Panian M; Würl P; Blümke K; Schmidt H; Meye A; Taubert H
    Cancer Gene Ther; 2004 Mar; 11(3):186-93. PubMed ID: 14739938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic nucleic acids as potential therapeutic tools for treatment of bladder carcinoma.
    Fuessel S; Meye A; Kraemer K; Kunze D; Hakenberg OW; Wirth MP
    Eur Urol; 2007 Feb; 51(2):315-26; discussion 326-7. PubMed ID: 16935415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
    Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
    Rieger C; Huebner D; Temme A; Wirth MP; Fuessel S
    Int J Oncol; 2015 Sep; 47(3):1121-30. PubMed ID: 26201840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells.
    Fuessel S; Kueppers B; Ning S; Kotzsch M; Kraemer K; Schmidt U; Meye A; Wirth MP
    J Urol; 2004 Jun; 171(6 Pt 1):2471-6. PubMed ID: 15126878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA; Sauk JJ; Nikitakis NG
    Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions.
    Kappler M; Rot S; Taubert H; Greither T; Bartel F; Dellas K; Hänsgen G; Trott KR; Bache M
    Cancer Gene Ther; 2007 Dec; 14(12):994-1001. PubMed ID: 17885676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.